Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Abhishek Kapoor Article rating: 3.9

The market opened in the green on 13th January. On Friday the Sensex rose by 0.36 percent to end at 41,599.72  and the Nifty was up by 0.33 percent to close at 12,256.80.  


Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Abhishek Kapoor Article rating: 4.9

The market opened in the green on 13th January, overall volumes in futures & options currently stand at 1.40 crore contracts with a turnover of Rs. 10,43,297.72  crore.


Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Abhishek Kapoor Article rating: 4.1

The market opened in the green on 13th January, overall volumes in futures & options currently stand at 1.40 crore contracts with a turnover of Rs. 10,43,297.72 crore.

Alembic Pharma receives USFDA nod for tablets treating depression
Alembic Pharma receives USFDA nod for tablets treating depression

Alembic Pharma receives USFDA nod for tablets treating depression

Anthony Fernandes Article rating: 4.7

Alembic Pharma announced that it has received the final approval from US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) of Vilazodone Hydrochloride Tablets, 10 mg, 20 mg and 40 mg. The approved ANDA is equivalent to the reference listed product, Viibryd Tablets, 10 mg, 20 mg and 40 mg of Allergan Sales Limited.

Sachin Bansal's Navi buys insurer, seeks bank licence
Sachin Bansal's Navi buys insurer, seeks bank licence

Sachin Bansal's Navi buys insurer, seeks bank licence

Rishikesh Gaikwad Article rating: 2.6
Flipkart co-founder Sachin Bansal has acquired a general insurance company and applied for a bank licence, as he takes rapid strides to build a diversified financial service business after leaving the online retailer in 2018.
CDC Group invests $57 million in Cholamandalam
CDC Group invests $57 million in Cholamandalam

CDC Group invests $57 million in Cholamandalam

Rishikesh Gaikwad Article rating: 5.0
CDC Group Plc, the UK government’s development finance institution, has invested Rs 400 crore in Cholamandalam Investment and Finance Company Ltd through 10-year masala bonds.
Index trend and stocks in action January 13, 2020
Index trend and stocks in action January 13, 2020

Index trend and stocks in action January 13, 2020

Karan Dsij Article rating: 5.0

The level of 12,300-12,330 would be a big hurdle for the bulls to climb; however, in case it crosses this hurdle, we can expect fireworks in the index. Meanwhile, the level of 12,100 is a key support. Stocks in news: Tata Steel, Yes Bank, HCC, Cholamandalam Investment and Finance, Lupin.

Optimism to continue on D-street
Optimism to continue on D-street

Optimism to continue on D-street

Karan Dsij Article rating: 5.0

The early trend on SGX Nifty indicates that the optimism on the D-street will continue to be the order of the day. At this moment, it is up by 41 points and signaling an opening around 12,332 levels. Further, if we look, the markets have entered into a data -heavy week, as heavyweights, such as HDFC Bank, IndusInd Bank, and Wipro are scheduled to announce their results during the week.

Indian benchmark closes higher amid volatility
Indian benchmark closes higher amid volatility

Indian benchmark closes higher amid volatility

Pratik Shastri Article rating: 4.5

The week started with a strong sell-off after US-Iraq war issues. Sensex and Nifty fell by nearly 800 and 230 points, intraday. The sentiment was further hampered after GDP forecast for FY20 was lowered to 5 per cent from earlier estimates of 6.1 per cent growth rate.

SPARC gives trendline breakout
SPARC gives trendline breakout

SPARC gives trendline breakout

Vinayak Gangule Article rating: 3.6

The stock of Sun Pharma Advanced Research Company Limited has given a downward sloping trendline breakout on the weekly timeframe. This breakout is confirmed by the above 50-week average volumes.

RSS
First24162417241824192421242324242425Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR